← Back to Search

Other

Cranberry Juice Product for Attention Deficit Disorder

N/A
Waitlist Available
Led By Alice Eggleston, PA-C, MPH
Research Sponsored by Ocean Spray Cranberries, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 7 days
Awards & highlights

Study Summary

This trial will test the effect of different doses of cranberry juice on cognitive function and mood in healthy adults.

Eligible Conditions
  • Attention Deficit Disorder
  • Depression

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~7 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 7 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
To evaluate in healthy adults the effect of 7-day consumption of cranberry beverages compared to placebo on attention.
Secondary outcome measures
To evaluate in healthy adults the effect of 7-day consumption of cranberry beverages compared to placebo on measures of alertness.
To evaluate in healthy adults the effect of 7-day consumption of cranberry beverages compared to placebo on measures of cognition (accuracy of performance).
To evaluate in healthy adults the effect of 7-day consumption of cranberry beverages compared to placebo on measures of cognition (speed of performance).
+3 more
Other outcome measures
To evaluate in healthy adults the safety and tolerability of 7-day consumption of cranberry beverages compared to placebo (Blood Pressure).
To evaluate in healthy adults the safety and tolerability of 7-day consumption of cranberry beverages compared to placebo (Body Temperature).
To evaluate in healthy adults the safety and tolerability of 7-day consumption of cranberry beverages compared to placebo (Heart Rate).
+3 more

Trial Design

6Treatment groups
Experimental Treatment
Group I: Third Product Order: order not stated to protect study blindingExperimental Treatment1 Intervention
Participants will receive each of the 6 study products sequentially in a cross-over design, consuming one study product for 7 days, followed by a 7 day wash-out period before beginning the next product in the sequence
Group II: Sixth Product Order: order not stated to protect study blindingExperimental Treatment1 Intervention
Participants will receive each of the 6 study products sequentially in a cross-over design, consuming one study product for 7 days, followed by a 7 day wash-out period before beginning the next product in the sequence
Group III: Second Product Order: order not stated to protect study blindingExperimental Treatment1 Intervention
Participants will receive each of the 6 study products sequentially in a cross-over design, consuming one study product for 7 days, followed by a 7 day wash-out period before beginning the next product in the sequence
Group IV: Fourth Product Order: order not stated to protect study blindingExperimental Treatment1 Intervention
Participants will receive each of the 6 study products sequentially in a cross-over design, consuming one study product for 7 days, followed by a 7 day wash-out period before beginning the next product in the sequence
Group V: First Product Order: order not stated to protect study blindingExperimental Treatment1 Intervention
Participants will receive each of the 6 study products sequentially in a cross-over design, consuming one study product for 7 days, followed by a 7 day wash-out period before beginning the next product in the sequence.
Group VI: Fifth Product Order: order not stated to protect study blindingExperimental Treatment1 Intervention
Participants will receive each of the 6 study products sequentially in a cross-over design, consuming one study product for 7 days, followed by a 7 day wash-out period before beginning the next product in the sequence
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cranberry Juice Product
2021
N/A
~30

Find a Location

Who is running the clinical trial?

Atlantia Food Clinical TrialsIndustry Sponsor
41 Previous Clinical Trials
4,211 Total Patients Enrolled
Ocean Spray Cranberries, Inc.Lead Sponsor
5 Previous Clinical Trials
474 Total Patients Enrolled
Alice Eggleston, PA-C, MPHPrincipal InvestigatorAtlantia Clinical Trials Ltd.
1 Previous Clinical Trials
60 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
Utah
Texas
Illinois
How old are they?
18 - 65
What site did they apply to?
Atlantia Clinical Trials Ltd
What portion of applicants met pre-screening criteria?
Met criteria

How responsive is this trial?

Typically responds via
Phone Call
Most responsive sites:
  1. Atlantia Clinical Trials Ltd: < 24 hours
Average response time
  • < 1 Day
Recent research and studies
clinicaltrials.govStudy
A Study to Assess the Synergistic Effects of a Cranberry Beverage on Cognitive Function
2021. "A Study to Assess the Synergistic Effects of a Cranberry Beverage on Cognitive Function". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05008549.
~7 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top